Project Grant HC060398136

Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $620,820 Project Grant awarded August 1, 2025, by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). This five-year award, concluding July 31, 2030, supports a single-arm Phase III clinical trial evaluating the efficacy of cryopreserved human umbilical cord (HUC) grafts as meningeal patches in...

Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $623,432 Project Grant award from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) to develop enhanced imaging goggles for fluorescence-guided surgery (FGS). The award, effective May 7, 2026, through April 30, 2031, supports an academic-industrial partnership focused on advancing the Cancer Vision Goggle (CVG) system to address the persistently high...

This $437,461 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a novel stabilization catheter device for His pacing lead implantation. The goal is to improve the accuracy and ease of His bundle pacing, an emerging alternative cardiac resynchronization therapy (CRT) for heart failure patients. The project aims to refine a deployable suction-tipped lead...

Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $467,542 project grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded August 15, 2025, with completion targeted for July 31, 2027. The award supports development of a fully automated, open-source computational pipeline utilizing deep learning algorithms and regional radiomics...

Federal Grant Award Summary Orygyn Medical Devices, LLC received a $613,556 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 1, 2025 through December 31, 2026. The company is developing a Tubal Selective Delivery System (TSDS), branded as FertChx, a novel medical device designed to provide office-based evaluation of fallopian tube patency during...

The National Heart, Lung, and Blood Institute (NHLBI) awarded UCLA a $534,761 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to develop magnetoelastic vascular grafts (MVGs) as an innovative platform technology for continuous stenosis monitoring. The MVG research aims to address a critical clinical need, as approximately 40% of the 3 million vascular grafts implanted annually experience reduced patency within two years. The project, running from September 1,...

This $717,712 Project Grant from the National Science Foundation's Division of Information and Intelligent Systems, under the Computer and Information Science and Engineering program (CFDA 47.070), will support the development and evaluation of a knowledge-enhanced and interpretable radiology report generation framework using longitudinal, multimodal electronic health record data and domain knowledge. The awardee, Joan & Sanford I Weill Medical College of Cornell University, will build a...

Federal Cooperative Agreement Award Summary The Johns Hopkins University received a $3.94 million Cooperative Agreement from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion expected August 31, 2026. This award funds the ASTRO (Adjuvant Steroid Injection Outcomes in Idiopathic Subglottic Stenosis) trial, a multicenter, prospective, randomized, double-blinded, placebo-controlled...

Federal Grant Award Summary Georgia TECH Research Corp received a $418,284 Project Grant from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, effective September 1, 2025, through August 31, 2027, funds research and development of an ion-selective, sensor-integrated central venous catheter (CVC) system for real-time monitoring and automated correction of...

Federal Cooperative Agreement Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $921,009 Cooperative Agreement on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct the ASTRO (Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis) trial. This multicenter, prospective, randomized, double-blinded, placebo-controlled clinical trial will evaluate the safety and efficacy of serial intralesional...